"Cost-Benefit Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. Cost effectiveness compares alternative ways to achieve a specific set of results.
Descriptor ID |
D003362
|
MeSH Number(s) |
N03.219.151.125
|
Concept/Terms |
Cost-Benefit Analysis- Cost-Benefit Analysis
- Analyses, Cost-Benefit
- Analysis, Cost-Benefit
- Cost-Benefit Analyses
- Cost Benefit Analysis
- Analyses, Cost Benefit
- Analysis, Cost Benefit
- Cost Benefit Analyses
Cost-Utility Analysis- Cost-Utility Analysis
- Analyses, Cost-Utility
- Analysis, Cost-Utility
- Cost Utility Analysis
- Cost-Utility Analyses
Economic Evaluation- Economic Evaluation
- Economic Evaluations
- Evaluation, Economic
- Evaluations, Economic
Marginal Analysis- Marginal Analysis
- Analyses, Marginal
- Analysis, Marginal
- Marginal Analyses
Cost Benefit- Cost Benefit
- Costs and Benefits
- Benefits and Costs
|
Below are MeSH descriptors whose meaning is more general than "Cost-Benefit Analysis".
Below are MeSH descriptors whose meaning is more specific than "Cost-Benefit Analysis".
This graph shows the total number of publications written about "Cost-Benefit Analysis" by people in this website by year, and whether "Cost-Benefit Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 3 | 4 |
1995 | 0 | 7 | 7 |
1996 | 1 | 5 | 6 |
1997 | 0 | 7 | 7 |
1998 | 0 | 15 | 15 |
1999 | 1 | 11 | 12 |
2000 | 0 | 9 | 9 |
2001 | 1 | 8 | 9 |
2002 | 2 | 9 | 11 |
2003 | 0 | 20 | 20 |
2004 | 1 | 14 | 15 |
2005 | 2 | 17 | 19 |
2006 | 0 | 15 | 15 |
2007 | 1 | 21 | 22 |
2008 | 1 | 18 | 19 |
2009 | 2 | 18 | 20 |
2010 | 1 | 17 | 18 |
2011 | 0 | 24 | 24 |
2012 | 2 | 31 | 33 |
2013 | 0 | 25 | 25 |
2014 | 6 | 32 | 38 |
2015 | 7 | 32 | 39 |
2016 | 6 | 28 | 34 |
2017 | 11 | 25 | 36 |
2018 | 10 | 25 | 35 |
2019 | 8 | 24 | 32 |
2020 | 8 | 30 | 38 |
2021 | 6 | 26 | 32 |
2022 | 1 | 12 | 13 |
2023 | 1 | 11 | 12 |
2024 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cost-Benefit Analysis" by people in Profiles.
-
Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention. JAMA Netw Open. 2024 Feb 05; 7(2):e2356078.
-
Portable Air Purifiers to Mitigate the Harms of Wildfire Smoke for People with Asthma. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):126-128.
-
Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. Pharmacoeconomics. 2024 Apr; 42(4):409-418.
-
Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 02; 7(1):e2352427.
-
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients. Age Ageing. 2024 Jan 02; 53(1).
-
Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial. Lancet Glob Health. 2023 Dec; 11(12):e1922-e1930.
-
Cost-effectiveness of a real-time spatiotemporal mapping surveillance system for meticillin-resistant Staphylococcus aureus prevention. J Hosp Infect. 2024 Jan; 143:178-185.
-
Delphi: A Democratic and Cost-Effective Method of Consensus Generation in Transplantation. Transpl Int. 2023; 36:11589.
-
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma. Blood Adv. 2023 06 13; 7(11):2494-2495.
-
Oral Azacitidine for Maintenance Treatment of Acute Myeloid Leukaemia After Induction Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2023 08; 41(8):857-867.